WUWooram Um

Wooram Um

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wooram Um has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Dong Gil You

    School of Chemical Engineering, Sungkyunkwan University, Suwon, Republic of Korea

    1 shared publication
  • Hong Yeol Yoon

    Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea

    1 shared publication
  • Ick Chan Kwon

    Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea

    1 shared publication
  • Jae Hyung Park

    Department of Intelligent Electronics and Computer Engineering, Chonnam National University, Gwangju 61186, Republic of Korea

    1 shared publication
  • Kwangmeyung Kim

    College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea

    1 shared publication
  • Sangmin Jeon

    School of Chemical Engineering, Sungkyunkwan University, Suwon, Republic of Korea

    1 shared publication

Latest Publications

  • Open Access

    Deep tissue penetration of nanoparticles using pulsed-high intensity focused ultrasound

    by Dong Gil You, Hong Yeol Yoon, Sangmin Jeon, Wooram Um, Sejin Son, Jae Hyung Park, Ick Chan Kwon, Kwangmeyung Kim

    Recently, ultrasound (US)-based drug delivery strategies have received attention to improve enhanced permeation and retention (EPR) effect-based passive targeting efficiency of nanoparticles in vitro and in vivo conditions. Among the US treatment techniques, pulsed-high intensity focused ultrasound (pHIFU) have specialized for improving tissue penetration of various macromolecules and nanoparticles without irreversible tissue damages. In this study, we have demonstrated that pHIFU could be utilized to improve tissue penetration of fluorescent dye-labeled glycol chitosan nanoparticles (FCNPs) in femoral tissue of mice. pHIFU could improve blood flow of the targeted-blood vessel in femoral tissue. In addition, tissue penetration of FCNPs was specifically increased 5.7-, 8- and 9.3-folds than that of non-treated (0 W pHIFU) femoral tissue, when the femoral tissue was treated with 10, 20 and 50 W of pHIFU, respectively. However, tissue penetration of FCNPs was significantly reduced after 3 h post-pHIFU treatment (50 W). Because overdose (50 W) of pHIFU led to irreversible tissue damages, including the edema and chapped red blood cells. These overall results support that pHIFU treatment can enhance the extravasation and tissue penetration of FCNPs as well as induce irreversible tissue damages. We expect that our results can provide advantages to optimize pHIFU-mediated delivery strategy of nanoparticles for further clinical applications.